Thick and thin: Rising sentiment will spur demand for treatments, but a patent cliff threatens profit.
Revenue for hair loss treatment manufacturers is expected to grow steadily over the next five years, supported by a patent cliff for major products Rogaine and Propecia. While the companies that manufacture these products will likely face a decline in profit, consumers will purchase more generic hair loss treatments. Furthermore, the aging population will increase the instances of male pattern baldness, boosting demand.
This industry develops and produces solutions that prevent or restore hair loss. Products in this industry include topical applications, orally ingestible treatments, hair transplants and laser follicle stimulation.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities
and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.